#ACR19 – [Not Published Yet] Study: Hydroxychloroquine May Reduce the Risk of Recurrent Congenital Heart Block in Subsequent Pregnancies of Women with Anti-SSA/Ro Antibodies

Physicians Should Consider Hydroxychloroquine to Reduce the Risk of Recurrent Congenital Heart Block in Subsequent Pregnancies of Women with Anti-SSA/Ro Antibodies – American College of Rheumatology (free)

Abstract: The Prospective Open Label Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH) Study Demonstrates a Reduction in the Recurrence Rate of Advanced Block (free)

#ACR19 – Just Presented at the 2019 American College of Rheumatology Annual Meeting